Company: BDRX
Filing Date: 2025-01-21
Form Type: 424B3
Source: 0001214659-25-000936
Chunk: 65

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-01-21
Form: 424B3
Chunk 65
---
 or any similar successor statute (collectively, the “”), and applicable state securities laws.

NOW, THEREFORE, in
consideration of the promises and the mutual covenants contained herein and other good and valuable consideration, the receipt and sufficiency
of which are hereby acknowledged, the Company and the Buyer hereby, intending to be legally bound, agree as follows:

1. .

As used in this Agreement, the
following terms shall have the following meanings:

a. “”
means the Buyer, any transferee or assignee thereof to whom the Buyer assigns its rights under this Agreement in accordance with and who agrees to become bound by the provisions of this Agreement, and any transferee or assignee thereof to whom a transferee
or assignee assigns its rights under this Agreement in accordance with and who agrees to become bound by the provisions
of this Agreement.

b. “”
means any individual or entity including but not limited to any corporation, a limited liability company, an association, a partnership,
an organization, a business, an individual, a governmental or political subdivision thereof or a governmental agency.

c. “,”
“,” and “” refer to a registration effected by preparing and filing one or
more Registration Statements of the Company in compliance with the Securities Act and pursuant to Rule 415 under the Securities Act or
any successor rule providing for offering securities on a continuous basis (“”), and the declaration or ordering
of effectiveness of such Registration Statement(s) by the United States Securities and Exchange Commission (the “”).

d. “” means all of the Commitment Shares and all of the Purchase Shares that may, from time to time, be issued or become
issuable to the Investor under the Purchase Agreement (without regard to any limitation or restriction on purchases), and any and all
shares of capital shares issued or issuable with respect to the Purchase Shares, the Commitment Shares or the Purchase Agreement as a
result of any share split, share dividend, recapitalization, Depositary Share-Ordinary Share ratio change, exchange or similar event or
otherwise, without regard to any limitation on purchases under the Purchase Agreement, in each case until such time as such securities
cease to be Registrable Securities pursuant to Section 2(e).

e. “” means one or more registration statements of the Company covering only the resale of the Registrable Securities,
including, for the avoidance of doubt, any New Registration Statement (as defined below).

2. .

a. The Company shall, within forty-five (45) calendar